查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790430

美國DNA 合成市場規模、佔有率和趨勢分析報告：按服務類型、應用、最終用途和細分市場預測，2025 年至 2033 年

U.S. DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Application (Research Development, Diagnostics), By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國DNA合成市場摘要

美國DNA合成市場規模預計在2024年達到12.5億美元，預計到2033年將達到46.2億美元，2025年至2033年的複合年成長率為15.93%。這一強勁成長主要源自於合成生物學、個人化醫療和生物技術研究領域日益成長的需求。美國基因編輯技術的進步和DNA合成成本的下降進一步加速了市場擴張。由於強大的研發投入和完善的生物技術基礎設施，美國仍是全球基因組學創新的關鍵參與者。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國DNA 合成市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場前景。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國DNA合成市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國DNA 合成市場：按服務類型進行的估計和趨勢分析

  • 細分儀表板
  • 美國DNA合成市場服務類型波動分析
  • 美國DNA 合成市場規模及趨勢分析（依服務類型），2021 年至 2033 年
  • 寡核苷酸合成
    • 按類型
    • 按長度
  • 基因合成
    • 按類型
    • 按長度

第5章：美國DNA 合成市場：依應用進行的估算與趨勢分析

  • 細分儀表板
  • 美國DNA合成市場應用波動分析
  • 美國DNA 合成市場規模與應用趨勢分析（2021-2033 年）
  • 研究與開發
    • 寡核苷酸合成
    • 基因合成
  • 診斷
  • 治療藥物
    • RNAi療法
    • 反義和寡核苷酸治療方法
    • 其他

第6章：美國DNA 合成市場：依最終用途的估算與趨勢分析

  • 細分儀表板
  • 美國DNA 合成市場波動分析（依最終用途）
  • 美國DNA 合成市場規模及趨勢分析（依最終用途），2021 年至 2033 年
  • 生物製藥和診斷藥物公司
  • 學術研究機構
  • 受託研究機構

第7章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience
    • BIONEER CORPORATION
    • Eton Bioscience, Inc
    • LGC Biosearch Technologies
    • IBA Lifesciences GmbH
    • Eurofins Scientific
    • Integrated DNA Technologies, Inc.
    • Quintara Biosciences
    • GenScript
Product Code: GVR-4-68040-689-4

U.S. DNA Synthesis Market Summary

The U.S. DNA synthesis market size was estimated at USD 1.25 billion in 2024 and is projected to reach USD 4.62 billion by 2033, expanding at a CAGR of 15.93% from 2025 to 2033. This high growth is driven by increasing demand in synthetic biology, personalized medicine, and biotechnology research. Advancements in gene editing technologies and declining costs of U.S. DNA synthesis are further accelerating market expansion. The U.S. remains a key player in global genomic innovation, supported by strong investment in R&D and a well-established biotech infrastructure.

U.S. DNA Synthesis Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. DNA synthesis market on the basis of service type, application, and end use.

  • Service Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Oligonucleotide Synthesis
    • By Type
    • Standard Oligonucleotide Synthesis
    • Custom Oligonucleotide Synthesis
    • By Length
    • Less than 50 nt
    • 51-100 nt
    • 101-150 nt
    • More than 150 nt
  • Gene Synthesis
    • By Type
    • Custom Gene Synthesis
    • Gene Library Synthesis
    • By Length
    • Less than 500 nt
    • 501-1000 nt
    • 1001-1500 nt
    • 1501-2000 nt
    • 2001-2500 nt
    • More than 2500 nt
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Research and Development
    • Oligonucleotide Synthesis
    • PCR
    • NGS
    • CRISPR
    • Cloning and Mutagenesis
    • Others
    • Gene Synthesis
    • Synthetic Biology
    • Vaccine Development
    • Genetic Engineering
    • Others
  • Diagnostics
  • Therapeutics
    • RNAi Therapies
    • Antisense Oligonucleotide-based Therapies
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical and Diagnostics Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. DNA Synthesis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. DNA synthesis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. DNA Synthesis Market: Service Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. DNA Synthesis Market Service Type Movement Analysis
  • 4.3. U.S. DNA Synthesis Market Size & Trend Analysis, by Service Type, 2021 to 2033 (USD Million)
  • 4.4. Oligonucleotide synthesis
    • 4.4.1. Oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. By Type
      • 4.4.2.1. Standard oligonucleotides synthesis
        • 4.4.2.1.1. Standard oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.2. Custom oligonucleotide synthesis
        • 4.4.2.2.1. Custom oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. By Length
      • 4.4.3.1. Less than 50nt
        • 4.4.3.1.1. Less than 50nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.2. 51-100nt
        • 4.4.3.2.1. 51-100nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.3. 101-150nt
        • 4.4.3.3.1. 101-150nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.4. More than 150nt
        • 4.4.3.4.1. More than 150nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Gene synthesis
    • 4.5.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.2. By Type
      • 4.5.2.1. Custom gene synthesis
        • 4.5.2.1.1. Custom gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.2.2. Gene library synthesis
        • 4.5.2.2.1. Gene library synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3. By Length
      • 4.5.3.1. Less than 500nt
        • 4.5.3.1.1. Less than 500nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.2. 501-1000nt
        • 4.5.3.2.1. 501-1000nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.3. 1001-1500nt
        • 4.5.3.3.1. 1001-1500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.4. 1501-2000nt
        • 4.5.3.4.1. 1501-2000nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.5. 2001-2500nt
        • 4.5.3.5.1. 2001-2500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.6. More than 2500nt
        • 4.5.3.6.1. More than 2500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. DNA Synthesis Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. DNA Synthesis Market Application Movement Analysis
  • 5.3. U.S. DNA Synthesis Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Research & Development
    • 5.4.1. Research & development market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Oligonucleotide synthesis
      • 5.4.2.1. Oligonucleotide synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.2. PCR
        • 5.4.2.2.1. PCR synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.3. NGS
        • 5.4.2.3.1. NGS synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.4. CRISPR
        • 5.4.2.4.1. CRISPR synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.5. Cloning and mutagenesis
        • 5.4.2.5.1. Cloning and mutagenesis synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.6. Others
        • 5.4.2.6.1. Others synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Gene synthesis
      • 5.4.3.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.2. Synthetic biology
        • 5.4.3.2.1. Synthetic biology tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.3. Vaccine development
        • 5.4.3.3.1. Vaccine development synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.4. Genetic engineering
        • 5.4.3.4.1. Genetic engineering synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.5. Others
        • 5.4.3.5.1. Others synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Diagnostics
    • 5.5.1. Diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Therapeutics
    • 5.6.1. Therapeutics market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.2. RNAi therapies
      • 5.6.2.1. RNAi therapies market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.3. Antisense and oligonucleotide-based therapies
      • 5.6.3.1. Antisense and oligonucleotide-based therapies market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.4. Others
      • 5.6.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. DNA Synthesis Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. DNA Synthesis Market End Use Movement Analysis
  • 6.3. U.S. DNA Synthesis Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical & Diagnostic Companies
    • 6.4.1. Biopharmaceutical & diagnostic companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Contract Research Organizations
    • 6.6.1. Contract Research Organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Thermo Fisher Scientific Inc.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Service benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Twist Bioscience
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Service benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. BIONEER CORPORATION
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Service benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Eton Bioscience, Inc
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Service benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. LGC Biosearch Technologies
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Service benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. IBA Lifesciences GmbH
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Service benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Eurofins Scientific
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Service benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Integrated DNA Technologies, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Service benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Quintara Biosciences
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Service benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. GenScript
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Service benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. DNA synthesis market, by service type, 2021 - 2033 (USD Million)
  • Table 3 U.S. DNA synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 4 U.S. DNA synthesis market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. DNA synthesis market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segments snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 U.S. DNA synthesis market value, 2024 (USD billion)
  • Fig. 16 Market trends & outlook
  • Fig. 17 PESTEL analysis
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 U.S. DNA synthesis market: Service type outlook & key takeaways
  • Fig. 20 U.S. DNA synthesis market: Service type movement analysis
  • Fig. 21 Oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 22 Standard oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 23 Custom oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 24 Less than 50 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 25 51-100 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 26 101-150 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 27 More than 150 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 28 Gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 29 Custom gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 30 Gene library synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 31 Less than 500 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 32 501-1,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 33 501-1,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 34 1,501-2,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 35 2,001-2,500 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 36 More than 2,500 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 37 U.S. DNA synthesis Market: Application outlook & key takeaways
  • Fig. 38 U.S. DNA synthesis Market: Application movement analysis
  • Fig. 39 Research and development market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 40 Oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 41 PCR market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 42 NGS market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 43 CRISPR market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 44 Cloning and mutagenesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 45 Others market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 46 Gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 47 Synthetic biology market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 48 Vaccine development market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 49 Genetic engineering market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 50 Others market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 51 Diagnostics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 52 Therapeutics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 53 RNAi therapies market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 54 Antisense oligonucleotide-based therapies market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 55 Others market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 56 U.S. DNA synthesis market: End Use outlook & key takeaways
  • Fig. 57 U.S. DNA synthesis market: End Use movement analysis
  • Fig. 58 Biopharmaceutical and diagnostics companies market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 59 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 60 Contract research organizations market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 61 Strategic framework